Teacher Retirement System of Texas Sells 7,243 Shares of Encompass Health Co. (NYSE:EHC)

Teacher Retirement System of Texas cut its holdings in Encompass Health Co. (NYSE:EHC) by 13.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,185 shares of the company’s stock after selling 7,243 shares during the period. Teacher Retirement System of Texas’ holdings in Encompass Health were worth $4,265,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Avior Wealth Management LLC bought a new stake in Encompass Health during the third quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC grew its holdings in Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after purchasing an additional 127 shares during the last quarter. Tompkins Financial Corp bought a new position in shares of Encompass Health in the fourth quarter valued at approximately $46,000. Finally, V Square Quantitative Management LLC lifted its stake in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after buying an additional 177 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

EHC has been the topic of several recent analyst reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. KeyCorp raised their target price on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday, February 10th. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Finally, Barclays boosted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $107.67.

Encompass Health Stock Up 3.0 %

EHC opened at $99.99 on Tuesday. Encompass Health Co. has a fifty-two week low of $76.11 and a fifty-two week high of $104.55. The company has a market capitalization of $10.07 billion, a P/E ratio of 22.42, a P/E/G ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The firm’s fifty day moving average price is $98.13 and its two-hundred day moving average price is $97.20.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.68%. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 2.10% of the stock is owned by insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.